Synapse Dental is a trailblazing dental solution provider that strives to revolutionize the dental experience for both professionals and patients. Their flagship product, the Dental Pain Eraser, is an electronic dental anesthesia solution designed to alleviate oral pain without the use of drugs or injections. This innovative technology, powered by Advanced PulseWaveTM Neuromodulation, has garnered acclaim from practitioners for its ability to provide rapid and long-lasting pain relief during orthodontic procedures, dental work, canker sores, and tooth sensitivity. Founded in 2014 and based in the United States, Synapse Dental operates in the Health Care sector. The company recently secured a Venture Round investment on 22 September 2023 from the American Association of Orthodontists, indicating growing recognition and support within the industry. With its commitment to advancing pain-free and drug-free dentistry, Synapse Dental stands at the forefront of innovation in dental care, offering promising potential for future growth and impact.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | Unknown | 1 | American Association of Orthodontists | 22 Sep 2023 |
No recent news or press coverage available for Synapse Dental.